Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Windtree Therapeutics Inc (WINT)

Windtree Therapeutics Inc (WINT)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 48,601
  • Shares Outstanding, K 26,704
  • Annual Sales, $ 0 K
  • Annual Income, $ -32,570 K
  • 60-Month Beta -0.03
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 0.90
Trade WINT with:

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 2 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/21
See More
  • Average Estimate -0.30
  • Number of Estimates 1
  • High Estimate -0.30
  • Low Estimate -0.30
  • Prior Year -0.54
  • Growth Rate Est. (year over year) +44.44%

Price Performance

See More
Period Period Low Period High Performance
1-Month
1.6300 +15.95%
on 08/20/21
2.0800 -9.13%
on 09/01/21
+0.1700 (+9.88%)
since 08/17/21
3-Month
1.6300 +15.95%
on 08/20/21
2.4400 -22.54%
on 06/28/21
-0.3100 (-14.09%)
since 06/17/21
52-Week
1.5801 +19.61%
on 05/13/21
8.7500 -78.40%
on 09/29/20
-5.2300 (-73.46%)
since 09/17/20

Most Recent Stories

More News
Windtree to Present at the Oppenheimer Fall Healthcare Life Sciences and MedTech Summit

Windtree Therapeutics, Inc. (NasdaqCM: WINT), a biotechnology and medical device company focused on advancing multiple late-stage interventions for acute cardiovascular and pulmonary disorders, today announced...

WINT : 1.8900 (+3.85%)
Windtree Therapeutics Reports Second Quarter 2021 Financial Results and Provides Key Business Updates

Windtree Therapeutics, Inc. (NasdaqCM: WINT), a biotechnology and medical device company focused on advancing multiple late-stage interventions for acute cardiovascular and pulmonary disorders, today reported...

WINT : 1.8900 (+3.85%)
Windtree Appoints Randall White, Ph.D., as Vice President, Clinical Program Management

Windtree Therapeutics, Inc. (NasdaqCM: WINT), a biotechnology and medical device company focused on advancing multiple late-stage interventions for acute cardiovascular and pulmonary disorders, today announced...

BMY : 61.31 (+0.13%)
WINT : 1.8900 (+3.85%)
50+ Companies to Present at the Access to Giving Virtual Investor Conference on July 13th - 15th, 2021

an investor conference themed around investor education and advocacy begins next week, July 13 - 15, 2021. More than 50 companies are scheduled to conduct virtual presentations over the three-day period...

ACOG.VN : 1.770 (unch)
ACER : 2.46 (-0.40%)
ADXN : 9.24 (-4.54%)
AGRX : 1.0800 (+4.85%)
ATGN : 1.9600 (+4.26%)
ABIO : 3.10 (+1.64%)
AUUD : 2.69 (-14.33%)
BASA : 0.3299 (-0.03%)
BMRA : 4.65 (+10.71%)
BKTI : 2.99 (+2.40%)
BSFC : 6.4000 (+2.56%)
DTST : 5.27 (+0.76%)
DCTH : 9.12 (+0.44%)
DMIFF : 0.2200 (-4.35%)
DLPN : 12.36 (-0.56%)
FLUX : 6.38 (-4.63%)
GBNH : 8.85 (+0.57%)
HAVLF : 0.2275 (-0.57%)
ISDR : 27.17 (+3.01%)
INLB : 1.5800 (-6.51%)
KNWN : 2.4300 (+2.10%)
LXXGF : 0.3900 (-0.76%)
MKTY : 8.83 (+1.38%)
MMATF : 13.6500 (-2.15%)
MRVFF : 1.0500 (-2.78%)
NEPH : 9.03 (+0.67%)
NMTC : 4.05 (-7.74%)
NLSP : 2.63 (-4.01%)
OBLG : 2.50 (-0.79%)
PBLA : 2.16 (-6.09%)
POSAF : 1.0200 (+2.33%)
PCSA : 7.91 (+0.89%)
PTIX : 1.9200 (-1.03%)
QOEG : 0.1000 (+58.73%)
QIPT : 5.78 (-3.02%)
SNGX : 1.0800 (+1.89%)
STRR : 2.67 (-0.37%)
TGCB : 0.7500 (unch)
VERB : 1.9100 (+1.60%)
WTEQ.CN : 0.120 (unch)
WINT : 1.8900 (+3.85%)
AYRO : 3.64 (unch)
BCTX : 7.86 (+3.97%)
BTX : 11.95 (-3.40%)
HWAL : 1.7500 (-2.78%)
NMRD : 6.88 (+3.46%)
THBRF : 3.5000 (-3.05%)
TRIQ : 0.9999 (+11.10%)
Windtree to Present at Access to Giving Virtual Investor Conference

Windtree Therapeutics, Inc. (NasdaqCM: WINT), a biotechnology and medical device company focused on advancing multiple late-stage interventions for acute cardiovascular and pulmonary disorders, today announced...

WINT : 1.8900 (+3.85%)
Windtree to Present at the Ladenburg Thalmann 2021 Healthcare Conference (Virtual)

Windtree Therapeutics, Inc. (NasdaqCM: WINT), a biotechnology and medical device company focused on advancing multiple late-stage interventions for acute cardiovascular and pulmonary disorders, today announced...

WINT : 1.8900 (+3.85%)
Windtree Appoints Diane Carman, Esq. as Senior Vice President and General Counsel

/PRNewswire/ -- Windtree Therapeutics, Inc. (NasdaqCM: WINT), a biotechnology and medical device company focused on advancing multiple late-stage interventions for acute cardiovascular and pulmonary disorders,...

WINT : 1.8900 (+3.85%)
50+ Companies to Present at the Access to Giving Virtual Investor Conference on July 13th - 15th, 2021

an investor conference themed around investor education and advocacy is set for July 13-15, 2021. There will be 50+ companies conducting virtual presentations as well as private meetings with qualified...

ACOG.VN : 1.770 (unch)
ACER : 2.46 (-0.40%)
ADXN : 9.24 (-4.54%)
AGRX : 1.0800 (+4.85%)
ATGN : 1.9600 (+4.26%)
ABIO : 3.10 (+1.64%)
AUUD : 2.69 (-14.33%)
BASA : 0.3299 (-0.03%)
BKTI : 2.99 (+2.40%)
BSFC : 6.4000 (+2.56%)
DTST : 5.27 (+0.76%)
DCTH : 9.12 (+0.44%)
DMIFF : 0.2200 (-4.35%)
DLPN : 12.36 (-0.56%)
FLUX : 6.38 (-4.63%)
GBNH : 8.85 (+0.57%)
HAVLF : 0.2275 (-0.57%)
ISDR : 27.17 (+3.01%)
INLB : 1.5800 (-6.51%)
KNWN : 2.4300 (+2.10%)
LXXGF : 0.3900 (-0.76%)
MKTY : 8.83 (+1.38%)
MMATF : 13.6500 (-2.15%)
MRVFF : 1.0500 (-2.78%)
NEPH : 9.03 (+0.67%)
NMTC : 4.05 (-7.74%)
NLSP : 2.63 (-4.01%)
OBLG : 2.50 (-0.79%)
PBLA : 2.16 (-6.09%)
POSAF : 1.0200 (+2.33%)
PCSA : 7.91 (+0.89%)
PTIX : 1.9200 (-1.03%)
QOEG : 0.1000 (+58.73%)
QIPT : 5.78 (-3.02%)
SNGX : 1.0800 (+1.89%)
STRR : 2.67 (-0.37%)
TGCB : 0.7500 (unch)
VERB : 1.9100 (+1.60%)
WTEQ.CN : 0.120 (unch)
WINT : 1.8900 (+3.85%)
Thinking about buying stock in Windtree Therapeutics, Coherus Biosciences, Surface Oncology, Energous Corp, or Nokia?

, /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for WINT, CHRS, SURF, WATT, and NOK.

CHRS : 17.56 (+9.54%)
SURF : 7.10 (+18.14%)
WINT : 1.8900 (+3.85%)
WATT : 2.27 (+6.57%)
NOK : 5.50 (-2.14%)
Windtree Therapeutics Reports First Quarter 2021 Financial Results and Provides Key Business Updates

, /PRNewswire/ -- Windtree Therapeutics, Inc. (NasdaqCM: WINT), a biotechnology and medical device company focused on advancing multiple late-stage interventions for acute cardiovascular and pulmonary...

WINT : 1.8900 (+3.85%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 64% Sell with a Weakest short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Windtree Therapeutics, Inc. is a biotechnology company focused on developing novel surfactant therapies for respiratory diseases and other potential applications. The company's proprietary technology platform includes a synthetic, peptide-containing surfactant that is structurally similar to endogenous...

See More

Key Turning Points

3rd Resistance Point 2.0600
2nd Resistance Point 1.9900
1st Resistance Point 1.9400
Last Price 1.8900
1st Support Level 1.8200
2nd Support Level 1.7500
3rd Support Level 1.7000

See More

52-Week High 8.7500
Fibonacci 61.8% 6.0111
Fibonacci 50% 5.1651
Fibonacci 38.2% 4.3190
Last Price 1.8900
52-Week Low 1.5801

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar